Aligos Therapeutics Future Growth
Future criteria checks 2/6
Aligos Therapeutics's earnings are forecast to decline at 10.2% per annum while its annual revenue is expected to grow at 57.9% per year. EPS is expected to decline by 1.7% per annum.
Key information
-10.2%
Earnings growth rate
-1.7%
EPS growth rate
| Biotechs earnings growth | 42.4% |
| Revenue growth rate | 57.9% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 08 Nov 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | N/A | -133 | N/A | N/A | 2 |
| 12/31/2025 | 2 | -109 | N/A | -119 | 2 |
| 12/31/2024 | 4 | -71 | N/A | -89 | 3 |
| 9/30/2024 | 6 | -77 | -85 | -85 | N/A |
| 6/30/2024 | 8 | -76 | -85 | -85 | N/A |
| 3/31/2024 | 14 | -100 | -79 | -79 | N/A |
| 12/31/2023 | 16 | -88 | -79 | -79 | N/A |
| 9/30/2023 | 16 | -82 | -73 | -73 | N/A |
| 6/30/2023 | 17 | -82 | -70 | -70 | N/A |
| 3/31/2023 | 14 | -83 | -82 | -81 | N/A |
| 12/31/2022 | 14 | -96 | -80 | -79 | N/A |
| 9/30/2022 | 11 | -112 | -101 | -100 | N/A |
| 6/30/2022 | 8 | -126 | -110 | -108 | N/A |
| 3/31/2022 | 6 | -136 | -107 | -106 | N/A |
| 12/31/2021 | 4 | -128 | -117 | -116 | N/A |
| 9/30/2021 | 4 | -125 | -98 | -98 | N/A |
| 6/30/2021 | 2 | -125 | -90 | -89 | N/A |
| 3/31/2021 | 1 | -116 | -85 | -84 | N/A |
| 12/31/2020 | N/A | -109 | -76 | -74 | N/A |
| 9/30/2020 | N/A | -92 | -72 | -70 | N/A |
| 6/30/2020 | N/A | -73 | -69 | -66 | N/A |
| 3/31/2020 | N/A | -62 | -61 | -58 | N/A |
| 12/31/2019 | N/A | -52 | -50 | -47 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 5WK0 is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: 5WK0 is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: 5WK0 is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: 5WK0's revenue (57.9% per year) is forecast to grow faster than the German market (5.6% per year).
High Growth Revenue: 5WK0's revenue (57.9% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 5WK0's Return on Equity is forecast to be high in 3 years time